Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280538962> ?p ?o ?g. }
- W4280538962 abstract "Abstract Background For people with advanced-stage Kaposi’s sarcoma (KS), a common HIV-associated malignancy in sub-Saharan Africa, mortality is estimated to be 45% within 2 years after KS diagnosis, despite increasingly wide-spread availability of antiretroviral therapy and chemotherapy. For advanced-stage KS, chemotherapy in addition to antiretroviral therapy improves outcomes and saves lives, but currently, only ~50% of people with KS in western Kenya who have an indication for chemotherapy actually receive it. This protocol describes the evaluation of a multicomponent patient navigation strategy that addresses common barriers to service penetration of and fidelity to evidence-based chemotherapy among people with advanced-stage KS in Kenya. Methods This is a hybrid type III effectiveness-implementation study using a non-randomized, pre- post-design nested within a longitudinal cohort. We will compare the delivery of evidence-based chemotherapy for advanced-stage KS during the period before (2016–2020) to the period after (2021–2024), the rollout of a multicomponent patient navigation strategy. The multicomponent patient navigation strategy was developed in a systematic process to address key determinants of service penetration of and fidelity to chemotherapy in western Kenya and includes (1) physical navigation and care coordination, (2) video-based education, (3) travel stipend, (4) health insurance enrollment assistance, (5) health insurance stipend, and (6) peer mentorship. We will compare the pre-navigation period to the post-navigation period to assess the impact of this multicomponent patient navigation strategy on (1) implementation outcomes: service penetration (chemotherapy initiation) and fidelity (chemotherapy completion) and (2) service and client outcomes: timeliness of cancer care, mortality, quality of life, stigma, and social support. We will also describe the implementation process and the determinants of implementation success for the multicomponent patient navigation strategy. Discussion This study addresses an urgent need for effective implementation strategies to improve the initiation and completion of evidence-based chemotherapy in advanced-stage KS. By using a clearly specified, theory-based implementation strategy and validated frameworks, this study will contribute to a more comprehensive understanding of how to improve cancer treatment in advanced-stage KS." @default.
- W4280538962 created "2022-05-22" @default.
- W4280538962 creator A5004055853 @default.
- W4280538962 creator A5009636499 @default.
- W4280538962 creator A5011059813 @default.
- W4280538962 creator A5012446068 @default.
- W4280538962 creator A5022880334 @default.
- W4280538962 creator A5024622118 @default.
- W4280538962 creator A5028224724 @default.
- W4280538962 creator A5028589707 @default.
- W4280538962 creator A5033234285 @default.
- W4280538962 creator A5067655089 @default.
- W4280538962 creator A5083442290 @default.
- W4280538962 creator A5088420489 @default.
- W4280538962 date "2022-05-13" @default.
- W4280538962 modified "2023-10-14" @default.
- W4280538962 title "A type III effectiveness-implementation hybrid evaluation of a multicomponent patient navigation strategy for advanced-stage Kaposi’s sarcoma: protocol" @default.
- W4280538962 cites W1530880935 @default.
- W4280538962 cites W1535885350 @default.
- W4280538962 cites W1565730670 @default.
- W4280538962 cites W1883818916 @default.
- W4280538962 cites W1971765404 @default.
- W4280538962 cites W1994526997 @default.
- W4280538962 cites W2004009085 @default.
- W4280538962 cites W2011691375 @default.
- W4280538962 cites W2029743870 @default.
- W4280538962 cites W2030863659 @default.
- W4280538962 cites W2036921215 @default.
- W4280538962 cites W2038597076 @default.
- W4280538962 cites W2050755575 @default.
- W4280538962 cites W2051894473 @default.
- W4280538962 cites W2057327092 @default.
- W4280538962 cites W2060004321 @default.
- W4280538962 cites W2071854553 @default.
- W4280538962 cites W2077109464 @default.
- W4280538962 cites W2126340581 @default.
- W4280538962 cites W2129660502 @default.
- W4280538962 cites W2138039555 @default.
- W4280538962 cites W2140092196 @default.
- W4280538962 cites W2168391307 @default.
- W4280538962 cites W2266461706 @default.
- W4280538962 cites W2297626685 @default.
- W4280538962 cites W2334201740 @default.
- W4280538962 cites W2587316155 @default.
- W4280538962 cites W2750615195 @default.
- W4280538962 cites W2753275557 @default.
- W4280538962 cites W2765494549 @default.
- W4280538962 cites W2766863832 @default.
- W4280538962 cites W2892460999 @default.
- W4280538962 cites W2942764960 @default.
- W4280538962 cites W2943980188 @default.
- W4280538962 cites W2944356352 @default.
- W4280538962 cites W2948736612 @default.
- W4280538962 cites W2961094817 @default.
- W4280538962 cites W2980860335 @default.
- W4280538962 cites W3008567976 @default.
- W4280538962 cites W3009755924 @default.
- W4280538962 cites W3010235078 @default.
- W4280538962 cites W3080106748 @default.
- W4280538962 cites W3107659422 @default.
- W4280538962 cites W3152877990 @default.
- W4280538962 doi "https://doi.org/10.1186/s43058-022-00281-7" @default.
- W4280538962 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35562783" @default.
- W4280538962 hasPublicationYear "2022" @default.
- W4280538962 type Work @default.
- W4280538962 citedByCount "0" @default.
- W4280538962 crossrefType "journal-article" @default.
- W4280538962 hasAuthorship W4280538962A5004055853 @default.
- W4280538962 hasAuthorship W4280538962A5009636499 @default.
- W4280538962 hasAuthorship W4280538962A5011059813 @default.
- W4280538962 hasAuthorship W4280538962A5012446068 @default.
- W4280538962 hasAuthorship W4280538962A5022880334 @default.
- W4280538962 hasAuthorship W4280538962A5024622118 @default.
- W4280538962 hasAuthorship W4280538962A5028224724 @default.
- W4280538962 hasAuthorship W4280538962A5028589707 @default.
- W4280538962 hasAuthorship W4280538962A5033234285 @default.
- W4280538962 hasAuthorship W4280538962A5067655089 @default.
- W4280538962 hasAuthorship W4280538962A5083442290 @default.
- W4280538962 hasAuthorship W4280538962A5088420489 @default.
- W4280538962 hasBestOaLocation W42805389621 @default.
- W4280538962 hasConcept C144133560 @default.
- W4280538962 hasConcept C162853370 @default.
- W4280538962 hasConcept C169160293 @default.
- W4280538962 hasConcept C17744445 @default.
- W4280538962 hasConcept C199539241 @default.
- W4280538962 hasConcept C2780378061 @default.
- W4280538962 hasConcept C68595000 @default.
- W4280538962 hasConcept C71924100 @default.
- W4280538962 hasConceptScore W4280538962C144133560 @default.
- W4280538962 hasConceptScore W4280538962C162853370 @default.
- W4280538962 hasConceptScore W4280538962C169160293 @default.
- W4280538962 hasConceptScore W4280538962C17744445 @default.
- W4280538962 hasConceptScore W4280538962C199539241 @default.
- W4280538962 hasConceptScore W4280538962C2780378061 @default.
- W4280538962 hasConceptScore W4280538962C68595000 @default.
- W4280538962 hasConceptScore W4280538962C71924100 @default.
- W4280538962 hasFunder F4320337355 @default.
- W4280538962 hasFunder F4320337356 @default.
- W4280538962 hasIssue "1" @default.
- W4280538962 hasLocation W42805389621 @default.